Shire plc (LSE: SHP, NASDAQ: SHPG) will announce full year 2014 earnings on Thursday February 12, 2015.
Results press release will be issued at: 07:00 EST / 12:00 GMT
Investor conference call time: 09:00 EST / 14:00 GMT
Flemming Ornskov, Chief Executive Officer, Jeff Poulton, Interim Chief Financial Officer and Perry Sternberg, Head of Neuroscience and Commercial Excellence will host the investor and analyst conference call at 9:00 EST / 14:00 GMT.
The details of the conference call are as follows:
A replay of the presentation will be available for two weeks by phone and by webcast for three months. Details can be found on our Investor Relations website: .
+44 1256 894157
+1 781-482 0460
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics
Click here for the PDF version of this press release.